Achaogen, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 25 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-07-11: Reporting owner Bernstein Karen; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-06-14: Reporting owner Lieginger Kent; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-06-14: Reporting owner Gilbert Halley E; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-06-14: Reporting owner ROBERTS BRYAN E; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-07-11 | Bernstein Karen Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $22.93 exercise price | 2017-07-13 | |
| 2017-06-14 | Lieginger Kent Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $22.11 exercise price | 2017-06-16 | |
| 2017-06-14 | Gilbert Halley E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $22.11 exercise price | 2017-06-16 | |
| 2017-06-14 | ROBERTS BRYAN E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $22.11 exercise price | 2017-06-16 | |
| 2017-06-14 | Fischbach Michael Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $22.11 exercise price | 2017-06-16 | |
| 2017-06-14 | Smither John W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $22.11 exercise price | 2017-06-16 | |
| 2017-06-14 | DOYLE JOHN C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $22.11 exercise price | 2017-06-16 | |
| 2017-06-14 | STEA GREGORY Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $22.11 exercise price | 2017-06-16 | |
| 2017-06-14 | Colowick Alan Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $22.11 exercise price | 2017-06-16 | |
| 2017-03-17 holding as of filing | Swem Lee Officer (Chief Scientific Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $8.04 exercise price | 2017-03-17 | ||
| 2017-03-17 holding as of filing | Swem Lee Officer (Chief Scientific Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.99 exercise price | 2017-03-17 | ||
| 2017-03-17 holding as of filing | Swem Lee Officer (Chief Scientific Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.65 exercise price | 2017-03-17 | ||
| 2017-03-17 holding as of filing | Swem Lee Officer (Chief Scientific Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.65 exercise price | 2017-03-17 | ||
| 2017-03-17 holding as of filing | Swem Lee Officer (Chief Scientific Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.34 exercise price | 2017-03-17 | ||
| 2017-03-17 holding as of filing | Swem Lee Officer (Chief Scientific Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $23.62 exercise price | 2017-03-17 | ||
| 2017-03-17 holding as of filing | Swem Lee Officer (Chief Scientific Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $23.62 exercise price | 2017-03-17 | ||
| 2017-02-22 | Hillan Kenneth J. Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +160,000 160,000 owned after | $23.62 exercise price | 2017-02-24 | |
| 2017-02-22 | Hillan Kenneth J. Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $23.62 exercise price | 2017-02-24 | |
| 2017-02-22 | Wise Blake Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $23.62 exercise price | 2017-02-24 | |
| 2017-02-22 | Wise Blake Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $23.62 exercise price | 2017-02-24 | |
| 2017-02-22 | Schilke Tobin Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,400 50,400 owned after | $23.62 exercise price | 2017-02-24 | |
| 2017-02-22 | Schilke Tobin Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,600 12,600 owned after | $23.62 exercise price | 2017-02-24 | |
| 2017-02-22 | Sarpangal Zeryn Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $23.62 exercise price | 2017-02-24 | |
| 2017-02-22 | Sarpangal Zeryn Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $23.62 exercise price | 2017-02-24 | |
| 2017-01-04 | Gilbert Halley E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $14.88 exercise price | 2017-01-06 |